Oluwole, O., Benner, J., Palivela, M., Bognar, K., Adair, N., Cianciolo, L., Sussman, M., Ray, M., Ghione, P. (2025). US cost consequence and time toxicity model for advanced therapies in the treatment for Relapsed/Refractory third-line or later diffuse large B-cell lymphoma: A comparison of axicabtagene ciloleucel with bispecific antibodies. Blood. https://doi.org/10.1182/blood-2025-6194